GPR55 and B-cell chronic lymphocytic leukemia: In the CLL group, the mean percentage of CD3, IBA1, and MAC387 positive cells co-expressing GPR55 were 78 ± 18.6%, 82 ± 10.8% and 70 ± 17.3%, respectively (Figure 8).